Teva Pharmaceutical Industries Ltd ADR diskutieren
Teva Pharmaceutical Industries Ltd ADR
WKN: 883035 / Symbol: TEVA / Name: Teva Pharma / Aktie / Pharmazeutika / Large Cap /
12,95 €
4,44 %
Buy Teva Pharmaceutical Industries Ltd ADR
Buy Teva Pharmaceutical Industries Ltd ADR
We offer Legitimately Cash & Asset Backed Financial Instruments on Lease
Worldwide project financing, Loans, BG, SBLC, DLC, LC
We arrange Following Bank Instruments
Letter of Credit ( LC)
From Various Banks in Singapore / HongKong / Europe /USA
Used For Import / Export Business and Trade Finance .
90/180DAYS
Bank Guarantee ( BG )
Fresh Cut
Slightly Seasoned
Seasoned
Stand By Letter of Credit ( SBLC )
90DAYS / 180/ 365DAYS
Regards
[email protected]
Steffen
Worldwide project financing, Loans, BG, SBLC, DLC, LC
We arrange Following Bank Instruments
Letter of Credit ( LC)
From Various Banks in Singapore / HongKong / Europe /USA
Used For Import / Export Business and Trade Finance .
90/180DAYS
Bank Guarantee ( BG )
Fresh Cut
Slightly Seasoned
Seasoned
Stand By Letter of Credit ( SBLC )
90DAYS / 180/ 365DAYS
Regards
[email protected]
Steffen
Buy with target price 10.0
Buy Teva Pharmaceutical Industries Ltd ADR
Sell with target price 10.0
Sell Teva Pharmaceutical Industries Ltd ADR
Teva Pharmaceutical Industries Limited (NYSE: TEVA) was upgraded by analysts at Evercore ISI to an "outperform" rating.
Ratings data for TEVA provided by MarketBeat
Teva Pharmaceutical Industries Limited (NYSE: TEVA) had its price target raised by analysts at Bank of America Co. from $12.00 to $13.00. They now have a "buy" rating on the stock.
Ratings data for TEVA provided by MarketBeat
Teva Pharmaceutical Industries Limited (NYSE: TEVA) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $13.00 price target on the stock, up previously from $11.00.
Ratings data for TEVA provided by MarketBeat
Teva Pharmaceutical Industries Limited (NYSE: TEVA) is now covered by analysts at HSBC Holdings plc. They set a "buy" rating and a $13.00 price target on the stock.
Ratings data for TEVA provided by MarketBeat
Teva Pharmaceutical Industries Limited (NYSE: TEVA) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $14.00 price target on the stock, up previously from $10.00.
Ratings data for TEVA provided by MarketBeat
Teva Pharmaceutical Industries Limited (NYSE: TEVA) had its price target raised by analysts at Barclays PLC from $14.00 to $15.00. They now have an "overweight" rating on the stock.
Ratings data for TEVA provided by MarketBeat
Teva Pharmaceutical Industries Limited (NYSE: TEVA) had its price target raised by analysts at Barclays PLC from $15.00 to $17.00. They now have an "overweight" rating on the stock.
Ratings data for TEVA provided by MarketBeat
Teva Pharmaceutical Industries Limited (NYSE: TEVA) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $19.00 price target on the stock, up previously from $12.00.
Ratings data for TEVA provided by MarketBeat
Neueste Beiträge
StockNews_com in TechnipFMC PLC diskutieren